XL413 T3352
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the activity of CDC7, which may result in the inhibition of DNA replication and mitosis, the induct
CAS nr:
1169558-38-6
Purity:
98%
Molecular Weight:
289,06
SMILES:
Clc1ccc2oc3c(nc([nH]c3=O)[C@@H]3CCCN3)c2c1
Formula:
C14H12ClN3O2
Pathway:
GPCR/G Protein,Cell Cycle/Checkpoint,JAK/STAT signaling,Chromatin/Epigenetic,Metabolism,Stem Cells
Target:
cholecystokinin,CDK,Pim,Pim,Casein Kinase,Casein Kinase
